Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.

Engineering adeno-associated virus vectors for gene therapy

Li, Chengwen, Samulski, R. Jude · 2020 · Nature Reviews Genetics

Abstract

Adeno-associated virus (AAV) vector-mediated gene delivery was recently approved for the treatment of inherited blindness and spinal muscular atrophy, and long-term therapeutic effects have been achieved for other rare diseases, including haemophilia and Duchenne muscular dystrophy. However, current research indicates that the genetic modification of AAV vectors may further facilitate the success of AAV gene therapy. Vector engineering can increase AAV transduction efficiency (by optimizing the transgene cassette), vector tropism (using capsid engineering) and the ability of the capsid and transgene to avoid the host immune response (by genetically modifying these components), as well as optimize the large-scale production of AAV.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41576-019-0205-4

Cites

193 of 193 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

Show all 192 references

Research works printed but not linked: 1

  1. Chan, Y. K. et al. Engineering AAV vectors to evade innate immune and inflammatory responses. Mol. Ther. 26, 457–458 (2018).

Cited by

See all 1,175

Metadata

Authors
Li, C., & Samulski, R. J.
Affiliations
University of North Carolina at Chapel Hill (US)
Corresponding author
  • Li, Chengwen
  • Samulski, R. Jude
Venue
Nature Reviews Genetics
Published
2020-02-10
Volume
21
Issue
4
Pages
255-272
ISSN
  • 1471-0056 (ISSN-L)
  • 1471-0064
OpenAlex
W3004887743
Cited by
1,175
References
192
Citations by year
2026: 136 · 2025: 183 · 2024: 253 · 2023: 204 · 2022: 166 · 2021: 169 · 2020: 64
FWCI
21.48
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Nature Reviews Genetics (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • National Heart, Lung, and Blood Institute (P01HL112761)
  • National Institute of Allergy and Infectious Diseases (R01AI072176)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
  • Health Sciences › Medicine › Genetics (clinical) › Neurogenetic and Muscular Disorders Research
Keywords
adeno-associated virus vectors, gene therapy, capsid engineering, transduction efficiency, vector tropism, immune evasion, AAV production, inherited blindness, spinal muscular atrophy, hemophilia, Duchenne muscular dystrophy
MeSH terms
Dependovirus, Genetic Engineering, Genetic Vectors, Immunity, Innate, Genetic Therapy, Adaptive Immunity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Engineering adeno-associated virus vectors for gene therapy. https://app.cochat.ai/papers/10.1038/s41576-019-0205-4
The paper
Li, C., & Samulski, R. J. (2020). Engineering adeno-associated virus vectors for gene therapy. Nature Reviews Genetics. https://doi.org/10.1038/s41576-019-0205-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.